SCLP — Scancell Holdings Share News
0.000.00%
- £116.64m
- £123.10m
REG - Scancell Hlds - Scancell to present at 2025 AACR Annual Meeting
AnnouncementREG - Scancell Hlds - Issue of share options
AnnouncementREG - Scancell Hlds - Scancell presenting at AACR IO conference
AnnouncementREG - Scancell Hlds - Interim Results
AnnouncementREG - Scancell Hlds - Notice of Interim Results
AnnouncementREG - Scancell Hlds - Modi-1 Vaccine Achieves Early Clinical Validation
AnnouncementREG - AIM - AIM Notice - 10/12/2024
AnnouncementREG - Scancell Hlds - Result of Retail Offer and Total Voting Rights
AnnouncementREG - Scancell Hlds - Result of Placing and Subscription
AnnouncementREG - Scancell Hlds - Retail Offer for up to £1 million
AnnouncementREG - Scancell Hlds - Proposed fundraise in excess of £8.5 million
AnnouncementREG - Scancell Hlds - Second Commercial License Agreement with Genmab
AnnouncementREG - Scancell Hlds - Positive data from Phase 2 SCOPE trial with SCIB1
AnnouncementREG - Scancell Hlds - Result of Annual General Meeting
AnnouncementREG - Scancell Hlds - Holding(s) in Company
AnnouncementREG - Scancell Hlds - Scancell Appoints Dr Phil L’Huillier as CEO
AnnouncementREG - Scancell Hlds - Notice of AGM
AnnouncementREG - Scancell Hlds - Results Year Ended 30 April 2024
AnnouncementREG - Scancell Hlds - Notice of Final Results
Announcement